
|Videos|June 28, 2021
Ideal Candidates for Factor VIII and Emicizumab for Hemophilia A
Robert Sidonio, Jr., MD, MSc, discusses treatment considerations and ideal candidates for factor VIII and emicizumab in patients with hemophilia A.
Advertisement
Episodes in this series

Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Targeted Combination Therapy for BRCA2-Mutated Prostate Cancer
2
Ribociclib Plus Fulvestrant Shows Strong PFS and OS Benefits in Patients With Invasive Lobular Carcinoma
3
Pharmacist Spotlight: Kelly Gable, PharmD, BCPP, FAAPP
4
Targeted ADCs Break Through Barriers in HER2-Positive Breast Cancer
5

















































































































































































































